logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Epix Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 71.4



Forward Citations = 124

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Thomas J McMurry (6 out of 15 patents)

silverMedal Randall B Lauffer (6 out of 22 patents)

bronzeMedal Xiang Y Yu (4 out of 35 patents)

4.  Daniel M Scott (4 out of 27 patents)

5.  Jian Lin (3 out of 48 patents)

6.  Yael Marantz (3 out of 18 patents)

7.  Oren Becker (3 out of 27 patents)

8.  Ashis K Saha (3 out of 22 patents)

9.  Nili Schutz (3 out of 5 patents)

10.  Mercedes Lobera (3 out of 11 patents)

11.  Hironao Sijiki (3 out of 6 patents)

12.  Robert M Weisskoff (3 out of 5 patents)

13.  Srinivasa Rao Cheruku (3 out of 19 patents)

14.  Victor J Cee (2 out of 40 patents)

15.  Peter Caravan (2 out of 17 patents)


14 patents:

1. 8080542 - S1P receptor modulating compounds and use thereof (2011-12-20),
2. 7919519 - S1P receptor modulating compounds and use thereof (2011-04-05),
3. 7855193 - S1P receptor modulating compounds and use thereof (2010-12-21),
4. 7790707 - S1P receptor modulating compounds and use thereof (2010-09-07),
5. 7412279 - Systems and methods for targeted magnetic resonance imaging of the vascular system (2008-08-12),
6. 7238341 - Peptide-based multimeric targeted contrast agents (2007-07-03),
7. 7229606 - Diagnostic imaging contrast agents with extended blood retention (2007-06-12),
8. 7186797 - Polypeptide conjugates with extended circulating half-lives (2007-03-06),
9. 7175829 - Contrast-enhanced diagnostic imaging method for monitoring interventional therapies (2007-02-13),
10. 7147837 - Bioactivated diagnostic imaging constrast agents (2006-12-12),
11. 7060250 - Diagnostic imaging contrast agents with extended blood retention (2006-06-13),
12. 7011815 - Diagnostic imaging contrast agents with extended blood retention (2006-03-14),
13. 6969507 - Imaging sexual response (2005-11-29),
14. 6925321 - Magnetic resonance angiography data (2005-08-02),
Company Overview
Epix Pharmaceuticals, Inc. is a biotechnology company based in Lexington, Massachusetts, specializing in the development of innovative therapeutics for various medical conditions. The company focuses on advancing its proprietary technology platforms to discover and develop novel small molecule drugs, particularly in the areas of cardiovascular and metabolic diseases. With a commitment to scientific excellence, Epix aims to address unmet medical needs through its research initiatives and collaborative partnerships in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

14 Patents

#49 in Lexington, MA

#1,364 in Massachusetts

#22,368 in US

#42,384 in the World

Lexington, MA (US)
Lexington, MA, United States of America

Epix Pharmaceuticals, Inc.

Forward Citations = 124

40 inventors:

goldMedal Thomas J McMurry (6 out of 15 patents)

silverMedal Randall B Lauffer (6 out of 22 patents)

bronzeMedal Xiang Y Yu (4 out of 35 patents)

4.  Daniel M Scott (4 out of 27 patents)

5.  Jian Lin (3 out of 48 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epix Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/epix-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…